BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2022 8:46:13 AM | Browse: 385 | Download: 999
 |
Received |
|
2022-01-09 12:20 |
|
Peer-Review Started |
|
2022-01-09 12:21 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-02-21 06:47 |
|
Revised |
|
2022-03-03 15:07 |
|
Second Decision |
|
2022-03-25 06:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-03-26 21:09 |
|
Articles in Press |
|
2022-03-26 21:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-26 12:42 |
|
Publish the Manuscript Online |
|
2022-05-13 08:46 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
PD-1 inhibitor in combination with fruquintinib therapy for initial unresectable colorectal cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong-Qiang Zhang, Chang-Zhi Huang, Jing-Yu Wu, Zhen-Ling Wang, Yu Shao and Zan Fu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zan Fu, MD, Chief Doctor, Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. fuzan1971@njmu.edu.cn |
| Key Words |
Colorectal cancer; Neoadjuvant; PD-1 inhibitors; Fruquintinib; MSI-H; Case report |
| Core Tip |
A 30-year-old man was diagnosed with microsatellite unstable colon cancer. Prior to his surgical treatment, he was treated with a neoadjuvant regimen of PD1 inhibitors in combination with fruquintinib. This neoadjuvant regimen is rarely used; however, this patient had a good outcome. Subsequently, we performed a laparoscopic radical resection of his right colon cancer, which revealed no microscopic tumour cells. The patient was in good condition after the surgical treatment. |
| Publish Date |
2022-05-13 08:46 |
| Citation |
Zhang HQ, Huang CZ, Wu JY, Wang ZL, Shao Y, Fu Z. PD-1 inhibitor in combination with fruquintinib therapy for initial unresectable colorectal cancer: A case report. World J Clin Cases 2022; 10(14): 4669-4675 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i14/4669.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i14.4669 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
